Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H SHEZF
Trading Information
- Previous Close Price
- $0.72
- Day Range
- $0.47–0.47
- 52-Week Range
- $0.47–0.47
- Bid/Ask
- $0.53 / $0.61
- Shares Outstanding
- 1.47B
- Market Cap
- $689.04M
- Volume/Avg
- 336 / 336
Key Statistics
- Price/Earnings (Normalized)
- 4.81
- Price/Sales
- 0.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 2,150
- Website
- https://www.hepalink.com
Valuation
|
Metric
|
SHEZF
|
|---|---|
Price/Earnings (Normalized) | 4.81 |
Price/Book Value | 0.41 |
Price/Sales | 0.89 |
Price/Cash Flow | 4.27 |
Price/Earnings
SHEZF
Financial Strength
|
Metric
|
SHEZF
|
|---|---|
Quick Ratio | 1.10 |
Current Ratio | 2.15 |
Interest Coverage | 7.36 |
Quick Ratio
SHEZF
Profitability
|
Metric
|
SHEZF
|
|---|---|
Return on Assets (Normalized) | 1.78% |
Return on Equity (Normalized) | 2.49% |
Return on Invested Capital (Normalized) | 2.10% |
Return on Assets
SHEZF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|p&N<<Fs? | LOCK|WjyXc | $68B | |||
| Haleon PLC ADR
HLN
| LOCK|S&>t&W | LOCK|$t | $42B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|rblx#n<N | LOCK|^&Rcb | $42B | |||
| Zoetis Inc Class A
ZTS
| LOCK|Q<l&nxB | LOCK|fd^ | $30B | |||
| Viatris Inc
VTRS
| LOCK|xlHzY?J | LOCK|>Gb | $19B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|nr | LOCK|zzP | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|&mQPG^y | LOCK|?L< | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|C$$pJFp | LOCK|%#t | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!%q!@c! | LOCK|mNhQ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|M$XVVh | LOCK|ng& | $2B |
United States